Tonsillectomy Reduces Doctor Visits/Medication Usage in Children
Better Sleep for Kids Starts Here At The Mann ENT Clinic, we treat more than just snoring—we help kids thrive. A major new study shows that removing the tonsils and adenoids (adenotonsillectomy) in children with even mild sleep-disordered breathing led to: 32% fewer doctor visits 48% less use of prescription medications This means your child
Sinus Procedures Shown to Reduce Headache and Facial Pain
If you suffer from chronic rhinosinusitis (CRS), you’re likely familiar with the persistent headaches and facial pain that come with it. These symptoms can significantly impact daily life, making it difficult to focus, sleep, and enjoy everyday activities. Fortunately, a recently published study provides promising news. Researchers conducted a systematic review of 26 studies, encompassing
Hearing Aid Use Linked to Lower Dementia and Mortality Risk
A recent study in the United States has brought to light some interesting findings about hearing loss and the use of hearing aids. The study looked at data from 9,885 adults and found that about 14.7% of them had hearing loss. However, only 12.7% of those with hearing loss were regularly using hearing aids. The
Sublingual Immunotherapy Shows Promise for Asthma Control
A recent study in the Journal of Allergy and Clinical Immunology suggests that sublingual immunotherapy (SLIT) reduces the need for inhaled steroids among patients with mild to moderate allergic asthma. Mann ENT was the first practice in North Carolina to provide sublingual immunotherapy for their patients approximately 15 years ago, and the practice has now
Revolutionary New Treatment Now Available for Sinusitis with Nasal Polyps
A new category of therapy is revolutionizing the treatment of advanced sinusitis with nasal polyps at Mann ENT. Known as Biologics, these novel injectable medications have previously provided impressive results for conditions such as allergic asthma and atopic dermatitis, as well as very promising results in treating previously fatal cancers. The FDA has recently approved